Aqualigne Ultra Draineur
Food supplement declared in France, declaration No 2016-10-497
Aqualigne Ultra Draineur (Laboratoires Vitarmonyl) is a food supplement declared in France. Status: retiré du marché le 31 July 2024. 3 rules of use apply to its ingredients (limits and warnings).
- Brand
- Laboratoires Vitarmonyl
- Food business operator placing the product on the market
- Laboratoires VITARMONYL
- Status
- Retiré du marché le 31 July 2024
- Form
- Flacon
- Daily dose
- 1 bouchon = 50 ml
- Directions for use
- à diluer dans un verre d'eau
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Allergie aux dérivés salicylés, À prendre en dehors des repas, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an)
- Objectives stated by the manufacturer (these are not authorised claims)
- Détoxifiant / Draineur
Declaration 157658, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie B (règlement (UE) 2022/2340).
- Conditions légales
Filipendula ulmaria (L.) Maxim.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retiré du marché le 31 July 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Cynara scolymus L. | Feuille | Extrait sec aqueux | 476 mg |
| Camellia sinensis (L.) Kuntze | Feuille | Extrait sec aqueux | 30 mg |
| Ribes nigrum L. | Feuille | Extrait sec aqueux | 10 mg |
| Cerasus vulgaris Mill. | Pédoncule | Extrait sec aqueux | 10 mg |
| Cichorium intybus L. | Racine | Extrait sec hydroalcoolique | 10 mg |
| Hieracium pilosella L. | Parties aériennes | Extrait sec aqueux | 10 mg |
| Calluna vulgaris (L.) Hull | Fleur | Extrait sec aqueux | 10 mg |
| Fraxinus excelsior L. | Feuille | Extrait sec aqueux | 10 mg |
| Arctium lappa L. | Racine | Extrait sec hydroalcoolique | 10 mg |
| Orthosiphon aristatus (Blume) Miq. | Feuille | Extrait sec aqueux | 10 mg |
| Viola tricolor L. | Parties aériennes | Extrait sec hydroalcoolique | 10 mg |
| Taraxacum campylodes G.E.Haglund | Feuille | Extrait sec hydroalcoolique | 10 mg |
| Filipendula ulmaria (L.) Maxim. | Parties aériennes | Extrait sec hydroalcoolique | 10 mg |
| Tilia cordata Mill. | Fleur | Extrait sec aqueux | 10 mg |
| Vitis vinifera L. | Fruit | Extrait sec aqueux | 10 mg |
Additives
E330, E412, E211, E202, E955
Other ingredients
Prunus persica (L.) Stokes, eau
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Arctium lappa L.
Read the warning, when it applies and the studies cited
Burdock - Arctium Lappa - Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Barnes et al. 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur.
Health Canada monograph dated 19 December 2025
BURDOCK - ARCTIUM LAPPA - Topical
Cautions and warnings
For external use only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Taraxacum campylodes G.E.Haglund
Read the warning, when it applies and the studies cited
DANDELION - TARAXACUM OFFICINALE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder or an intestinal obstruction (Brinker 2010; Godfrey et al. 2010; ESCOP 2003; Bradley 1992).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Constipation, Flushing of the urinary tract, Indigestion, and Loss of appetite.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Applies to products providing 10 g or more of dried leaf or dried root or dried whole plant, per day or 10 mL or more of juice, per day.
Do not use if you have diabetes or a blood pressure, kidney or cardiovascular disorder (Goksu et al. 2010; EMA 2009; Hunt et al. 2005; Green et al. 2002; Mujais and Katz 2000; Carlsen et al. 1990; Kuller et al. 1986; Artz et al. 1966).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking heart medications or other products containing diuretics (Goksu et al. 2010; EMA 2009; Hunt et al. 2005; Green et al. 2002; Mujais and Katz 2000; Carlsen et al. 1990; Kuller et al. 1986; Artz et al. 1966).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Tilia cordata Mill.
Read the warning, when it applies and the studies cited
Linden - TILIA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; De Smet 1993).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Laboratoires Vitarmonyl
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.